Wealth Alliance Grifols Sa Transaction History

Wealth Alliance

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$10.6 - $13.28 $43,057 - $53,943	4,062 Added 13.53%	34,093 $405,000
Q1 2022 May 10, 2022	SELL	$10.37 - $12.73 $3,204 - $3,933	-309 Reduced 1.02%	30,031 $351,000
Q4 2021 Feb 14, 2022	SELL	$10.21 - $15.27 $20,869 - $31,211	-2,044 Reduced 6.31%	30,340 $341,000
Q3 2021 Nov 12, 2021	BUY	$14.07 - $17.3 $110,379 - $135,718	7,845 Added 31.97%	32,384 $473,000
Q2 2021 Aug 16, 2021	BUY	$16.62 - $18.94 $64,984 - $74,055	3,910 Added 18.95%	24,539 $426,000
Q1 2021 May 18, 2021	SELL	$15.15 - $19.78 $15,907 - $20,769	-1,050 Reduced 4.84%	20,629 $357,000
Q4 2020 Feb 11, 2021	BUY	$16.86 - $19.67 $123,364 - $143,925	7,317 Added 50.95%	21,679 $399,000
Q3 2020 Nov 13, 2020	BUY	$15.4 - $20.16 $58,550 - $76,648	3,802 Added 36.0%	14,362 $249,000
Q2 2020 Aug 14, 2020	BUY	$18.24 - $21.45 $192,614 - $226,512	10,560 New	10,560 $193,000

147

151M

2.38M

662K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.57B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

Stay updated on Wealth Alliance with notifications on news.